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Abstract
The interaction with brain endothelial cells is central to the pathogenicity of Neisseria meningitidis infections. Here, we show
that N. meningitidis causes transient activation of acid sphingomyelinase (ASM) followed by ceramide release in brain
endothelial cells. In response to N. meningitidis infection, ASM and ceramide are displayed at the outer leaflet of the cell
membrane and condense into large membrane platforms which also concentrate the ErbB2 receptor. The outer membrane
protein Opc and phosphatidylcholine-specific phospholipase C that is activated upon binding of the pathogen to heparan
sulfate proteoglycans, are required for N. meningitidis-mediated ASM activation. Pharmacologic or genetic ablation of ASM
abrogated meningococcal internalization without affecting bacterial adherence. In accordance, the restricted invasiveness
of a defined set of pathogenic isolates of the ST-11/ST-8 clonal complex into brain endothelial cells directly correlated with
their restricted ability to induce ASM and ceramide release. In conclusion, ASM activation and ceramide release are essential
for internalization of Opc-expressing meningococci into brain endothelial cells, and this segregates with invasiveness of N.
meningitidis strains.
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Introduction
Neisseria meningitidis (Nm, the meningococcus) is a frequently
found asymptomatic colonizer of the upper respiratory tract,
which under certain circumstances may penetrate the mucosal
membrane, reach the bloodstream and cause septicemia and/or
meningitis. During the course of infection N. meningitidis is capable
to interact with a variety of human cells including epithelial as well
as peripheral and brain microvascular endothelial cells [1,2]. To
mediate association with this wide range of host cells, meningo-
coccci express a variety of adhesins and invasins, including type IV
pili (TfP) [3–5], the outer membrane proteins Opa and Opc and a
number of newly identified minor adhesion or adhesion-like
proteins [6–12]. As an important pathogenicity factor the integral
outer membrane protein (OMP) Opc is particularly implicated in
host cell invasion of endothelial cells [1,8,13,14]. Opc is a beta
barrel protein with five surface loops encoded by a single gene
(opcA) and is antigenically stable [15,16]. Opc expression is
controlled at the transcriptional level by the length of a polycytidine
stretch within its promoter region [17]. Opc is expressed by several
virulent N. meningitidis lineages, but is absent from certain epidemic
clones (ET-37/ST-11 clonal complex (cc)) and a few random
endemic isolates [18]. Two epidemiological studies reported
outbreaks where meningococcal strains of the ST-11 cc tend to
cause severe sepsis with fatal outcome, but rarely meningitis [19,20].
For N. meningitidis uptake, Opc links the meningococcus to the
extracellular matrix components and serum proteins vitronectin
and fibronectin followed by binding to avb3 or a5b1-integrins and
activation of phosphotyrosine signalling and cytoskeletal rear-
rangement [1,2,21–23]. As observed for human epithelial cells,
Opc can also bind to heparin-like molecules and to cell surface
heparan sulfate proteoglycans (HSPGs) [24], which can mediate
receptor interaction (referred to as cis-activation) to induce
signaling and subsequent internalization [25].
Adhesion of fully encapsulated meningococci to host cells is
facilitated primarily by pili. Though OMPs are partially masked
by the polysaccharide capsule, they also efficiently support
adhesion and invasion to eukaryotic cells especially on cells of
high receptor density as would be induced in inflammatory
conditions and/or lateral receptor aggregation [26].
Sphingomyelin is a major component of the outer plasma
membrane layer where, under certain conditions of stress or the
induction of inflammatory cytokines, it is metabolized into
ceramide and phosphorylcholine by the activity of the acid
sphingomyelinase (ASM). Once activated, this enzyme translocates
from its lysosomal intracellular storage to outer cell membrane
where it is co-displayed with released ceramides [27–35]. Due to
their biophysical properties, ceramide-enriched membrane do-
mains fuse into extended ceramide-enriched platforms which span
a few hundred nanometers to several micrometers [27,29]. In
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addition to altering membrane fluidity and rigidity, ceramide-
enriched platforms serve to sort and eventually concentrate
membrane receptors and membrane proximal signaling compo-
nents thereby amplifying cellular responses and signal transduction
[36]. Their role in enhancement of pathogen uptake has been
directly revealed for N. gonorrhoeae, Pseudomonas aeruginosa, as well as
rhinoviruses and measles virus [37–41]. In addition, Staphylococcus
aureus triggers the formation of ceramide-enriched membrane
platforms for induction of apoptosis [42]. It is as yet unknown
whether SMase activation and ceramide release relates to N.
meningitidis uptake especially in its natural target cells.
In this study we now show that N. meningitidis induces ASM
activation, ceramide release and formation of ceramide-enriched
platforms proximal to attached bacteria within the outer layer of
the membrane of brain endothelial cells. Ceramide-enriched
platforms in turn serve to cluster the ErbB2 receptor underneath
adherent bacteria. Opc and activation of phosphatidylcholine-
specific phospholipase C (PC-PLC) downstream of HSPGs is
critical for N. meningitidis ASM activation, which proved to be
crucial for N. meningitidis uptake but not adhesion. Stressing the
importance of ASM activation in N. meningitidis invasion and
pathogenesis, a less invasive defined set of pathogenic isolates of
the ST-11/ST-8 cc was substantially less capable of inducing ASM
activation and formation of ceramide-enriched platforms.
Results
Exposure of N. meningitidis to host cells induces ASM
activation, ceramide release and formation of ceramide-
enriched platforms
Because uptake of some pathogenic bacteria involved formation
of ceramide-enriched membrane platforms [37–39], we investi-
gated whether N. meningitidis employs a similar mechanism to infect
and enter into eukaryotic cells. To analyse whether N. meningitidis
stimulates surface display of ceramide on human brain microvas-
cular endothelial cells (HBMEC), cells were infected with the GFP-
expressing wildtype strain MC58 (ST-32 clonal complex (cc)),
fixed and stained with an anti-ceramide antibody (mAb 15B4). N.
meningitidis strain MC58 rapidly, but transiently induced formation
of large extrafacial ceramide-enriched platforms, which reached a
maximum within 2 hrs after infection (Fig. 1, Fig. S1) and
decreased thereafter. Bacteria adhered to the cells within
ceramide-enriched membrane platforms (Fig. 1A, upper panels).
In unexposed control cells, shallow ceramide-specific signals were
visible, but these were not condensed into large platforms (Fig. 1A,
lower panels).
Because surface accumulation of ceramides usually reflects acid
sphingomyelinase (ASM) rather than neutral sphingomyelinase
(NSM) activity, which acts on its substrate in the cytosolic layer, we
directly assessed activation of these enzymes in response to N.
meningitidis MC58 exposure directly in cell lysates or membrane
preparations (for NSM), respectively. Mirroring the kinetics of
extrafacial ceramide release (Fig. 1), N. meningitidis MC58 caused a
rapid ASM activation, which peaked within 2 hrs and subse-
quently declined (Fig. 2 A). In contrast, NSM was not stimulated
by N. meningitidis within this time frame (Fig. S2). The kinetics of
ASM and ceramide surface display were monitored by flow
cytometry (Fig. 2B–D) or by immunodetection of a ceramide-
specific antibody bound to intact cells (Fig. 2D, inset) at various
time intervals following N. meningitidis MC58 exposure. Irrespective
of the method used, ASM and ceramide were readily detectable on
the cell surface within 2 hrs and their expression declined
thereafter. Pre-treatment of cells with the functional ASM
inhibitor amitriptyline prevented surface release of ceramides
after N. meningitidis MC58 exposure indicating that this process
depends on ASM (Fig. 2E). Finally, while ASM was not and
ceramide was barely detectable on the surface of uninfected
HBMEC cells, both molecules were readily co-detected 2 hrs
following exposure of the cells to MC58 (Fig. 2F). N. meningitidis
MC58–induced ASM surface location and ceramide release were
not restricted to HBMEC as revealed by experiments involving
HBMEC/cib, which slightly differed with regard to the kinetics of
peak levels (3 hrs rather than 2 hrs), but not efficiency of ceramide
release (Fig. S3).
N. meningitidis triggers ASM induction and ceramide
release via activation of PC-PLC
Previous studies implicated a regulation of ASM by diacylgly-
cerol (DAG) release in response to phosphatidylcholine-specific
phospholipase C (PC-PLC) activity [43,44]. This also applied to
the related species, N. gonorrhoeae, where PC consumption by PC-
PLC activity released DAG resulting in ASM activation [37]. PC-
PLC activity was measured in lysates of HBMEC infected with N.
meningitidis MC58 over time in the presence or absence of the PC-
PLC inhibitor D609. N. meningitidis MC58 caused a significant PC-
PLC activation, which peaked within 2 hrs, and this was inhibited
by preincubation of HBMEC with D609 (Fig. S4). To rule out a
possible role of PC-PLC also in N. meningitidis driven ASM
activation, ASM activity was assessed in lysates of HBMEC that
were treated with the PC-PLC inhibitor D609 prior to infection.
D609 indeed blocked the activation of ASM during meningococ-
cal infection (Fig. 3A). Moreover, cell surface ceramide release was
significantly reduced in the presence of D609 as demonstrated by
flow cytometry 2 hrs following infection with N. meningitidis MC58
(Fig. 3B). To address a potential contribution of phospholipase A2
(PLA2) or phospholipase D (PLD) in DAG generation for ASM
activation, activity of the enzyme was assessed in lysates of
HBMEC treated with PLA2 inhibitor AACOCF3 or PLD inhibitor
Author Summary
Neisseria meningitidis, an obligate human pathogen, is a
causative agent of septicemia and meningitis worldwide.
Meningococcal infection manifests in a variety of forms,
including meningitis, meningococcemia with meningitis or
meningococcemia without obvious meningitis. The inter-
action of N. meningitidis with human cells lining the blood
vessels of the blood-cerebrospinal fluid barrier is a
prerequisite for the development of meningitis. As a
major pathogenicity factor, the meningococcal outer
membrane protein Opc enhances bacterial entry into
brain endothelial cells, however, mechanisms underlying
trapping of receptors and signaling molecules following
this interaction remained elusive. We now show that Opc-
expressing meningococci activate acid sphingomyelinase
(ASM) in brain endothelial cells, which hydrolyses sphin-
gomyelin to cause ceramide release and formation of
extended ceramide-enriched membrane platforms where-
in ErbB2, an important receptor involved in bacterial
uptake, clusters. Mechanistically, ASM activation relied on
binding of N. meningitidis to its attachment receptor,
HSPG, followed by activation of PC-PLC. Meningococcal
isolates of the ST-11 clonal complex, which are reported to
be more likely to cause severe sepsis, but rarely meningitis,
barely invaded brain endothelial cells and revealed a
highly restricted ability to induce ASM and ceramide
release. Thus, our results unravel a differential activation of
the ASM/ceramide system by the species N. meningitidis
determining its invasiveness into brain endothelial cells.
Differential Activation of ASM by Meningococci
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5-fluoro-2-indolyl des-chlorohalopemide (FIPI), respectively, prior
to infection. Indicating that these enzymes are not involved in
meningococcal ASM activation, these compounds did not affect
ASM activity (Fig. 3C) nor cell surface ceramide display (Fig. 3D).
For N. gonorrhoeae, PC consumption by PC-PLC is initiated by
binding of Opa-expressing strains to heparan sulphate proteogly-
cans (HSPGs) [37]. Opc is also able to mediate adhesion to and
invasion of epithelial cells by binding to HSPGs [24]. To analyse
whether PC-PLC and ASM are activated downstream of HSPGs,
two different experimental approaches were taken: ASM activity
was assessed in HBMEC infected in the presence of heparin that
blocks possible Opc-HSPG interactions, or cells were treated with
heparinase III, which cleaves heparan sulphate moieties, prior to
infection. Both conditions significantly reduced ASM activation by
N. meningitidis (Fig. 3E), along with meningococcal uptake into
HBMEC (Fig. 3F and G), indicating an important role of this
enzyme in this process.
Acid sphingomyelinase activation supports uptake of N.
meningitidis
To analyze whether ASM activation was of functional
importance in meningococcal uptake directly, HBMEC were
treated with the ASM inhibitor amitriptyline 30 min prior to
infection with N. meningitidis MC58 and an isogenic unencapsu-
lated mutant strain MC58 siaD, and adhesion and invasion were
determined over time. The unencapsulated mutant was included
into these experiments due to its higher invasive capacity [1].
Interestingly, ASM activation induced by MC58 siaD after 2 h
significantly exceeded that induced by wildtype MC58 (Fig. 4A).
As determined in gentamicin protection assays, pharmacological
ASM inhibition reduced intracellular accumulation of N. meningi-
tidis MC58 (Fig. 4B, right panel) and MC58 siaD (Fig. 4C) (about
70% inhibition with 10 mM amitriptyline at 4 h p.i. [P,0.05] and
about 80% inhibition at 8 h p.i. [P,0.05], dose-dependent data
shown for MC58 siaD only) (Fig. 4C). ASM inhibition did,
however, not affect adhesion of N. meningitidis to HBMEC as
determined by the estimation of cell-adherent bacteria (Fig. 4B,
left panel, for MC58, Fig. 4C for MC58 siaD) or bacterial growth
(data not shown). We took two independent genetic approaches to
verify the importance of the ASM for N. meningitidis invasion.
Firstly, RNAi-mediated knockdown of ASM transcripts reduced N.
meningitidis uptake by HBMEC by about 40% for MC58 and .
90% for MC58 siaD, while pathogen uptake was not affected by a
scrambled control siRNA (Fig. 4D and E). Secondly, we
comparatively analyzed N. meningitidis uptake into fibroblasts
derived from ASM2/2 or wild-type mouse embryos (MEFs).
Wild-type MEFs internalised N. meningitidis with similar kinetics,
but less efficiently (one log lower) than HBMEC, however, while
ASM-deficient MEFs were significantly impaired in the ability to
internalize N. meningitidis (Fig. 4F and G; later time points could not
be analyzed due to toxicity of the infection in these cultures).
ASM-deficient Niemann-Pick fibroblasts are significantly
less invaded by N. meningitidis
Finally, we comparatively analyzed N. meningitidis MC58 and
MC58 siaD uptake into human fibroblasts generated from healthy
donors or patients suffering from Niemann-Pick disease type A
(NPDA), a lysosomal storage disease, characterized by a lack of
ASM activity. In line with the data obtained for ASM siRNA
ablation and in ASM2/2 MEFs (Fig. 4D–G), N. meningitidis uptake
was severely reduced in NPDA-fibroblasts as compared to their
wild-type counterparts (Fig. 5A and B). When analyzed by
immunofluorescent staining, a significant proportion of cell-
associated meningococci localized within fibroblasts of healthy
controls, while the frequency of intracellular bacteria was
substantially lower in NPDA cells 4 h p.i. ((Fig. 5C and Fig. S5),
data shown for MC58 siaD) though equivalent amounts of cell-
attached bacteria were initially seen in all cultures. Altogether,
these findings clearly reveal that ASM activation by meningococci
is critical for bacterial uptake, but not adhesion.
Figure 1. N. meningitidis induces the formation of ceramide-enriched membrane platforms on brain endothelial cells (HBMEC).
HBMEC were infected with a GFP-expressing wildtype strain MC58 for 2 h (upper panels) or left uninfected (control cells, bottom panels), fixed, left
intact, stained with anti-ceramide antibodies and secondary Cy3-conjugated anti-mouse-IgM antibodies and analyzed by confocal microscopy.
Ceramides accumulate in close association with attached bacteria. The data are representative for 5 similar studies. Size bars represent 5 mm.
doi:10.1371/journal.ppat.1004160.g001
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Less invasive MenC isolates induce significantly less ASM
activation and ceramide release on HBMEC but not on
FaDu cells
To analyse whether N. meningitidis isolates belonging to different
serogroups and/or sequence types might differentially activate
ASM and ceramide release, we selected four pathogenic menin-
gococcal isolates of the ST-11/ST-8 cc that belong to serogroup C
(MenC strains WUE2121, DE7017, FAM18, DE6904) (Table 1).
In gentamicin protection assays, these isolates proved to be
significantly less invasive into HBMEC as compared to strain N.
meningitidis MC58, however, did not differ with regard to adhesion
Figure 2. N. meningitidis infection activates ASM and causes membrane ceramide accumulation on HBMEC. (A) ASM activity was
measured in whole cell lysates of HBMEC infected with N. meningitidis wildtype strain MC58 or not (control) after the indicated time intervals. Data
(mean 6 S.D.) were generated in three independent experiments, each performed in triplicate. (B to E) Surface ASM and ceramide levels on infected
HBMEC were determined by flow cytometry analysis or spot assays (shown in Fig. 2D, insert). (B) Surface display of ASM (upper row, purple line) and
ceramide (bottom row, red line) on HBMEC infected with N. meningitidis strain MC58 for 4 hrs, control, uninfected HBMEC. An isotype antibody
served as a negative control in staining experiments (both rows, green line) (MFI of isotype control ceramide= 9.7961.34; MFI of isotype control
ASM=13.1260.53). (C) Surface ASM levels on infected HBMEC were determined in three independent experiments performed in duplicates. (D)
Surface ceramide release on wildtype strain MC58 infected HBMEC (and, for control, uninfected cells) was determined by flow cytometry or spot
assays (inset). An isotype antibody served as a negative control in staining experiments. For the spot assay, HBMEC were infected with wildtype strain
MC58 and an isogenic, unencapsulated isolate MC58 siaD or were left uninfected (control) for 2 hrs. (E) Surface ceramide levels were estimated on
HBMEC treated with amitriptyline (open circles) or not (filled circles) prior to infection (MFI of isotype control ceramide= 8.6360.94). (F) Detection of
ASM or ceramides on HBMEC infected with MC58 (lower panel) or left uninfected (control, upper panel) by microscopy. As representatively shown,
ASM co-localized in ceramide-enriched membrane platforms on HBMEC upon infection with N. meningitidis. Size bars represent 10 mm. All data show
mean values 6 S.D. of three independent experiments done in duplicate. * P,0.05, ** P,0.01, *** P,0.001, relative to uninfected control cells or to
cells infected without inhibitor. Fluorescence microscopy studies are representative for 3 similar studies.
doi:10.1371/journal.ppat.1004160.g002
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Figure 3. Phosphatidylcholine-specific phospholipase C (PC-PLC) is involved in ASM activation and bacterial uptake by HBMEC.
HBMEC were treated with the PC-PLC inhibitor D609 (100 mM) 30 min prior to infection with N. meningitidis MC58 or left untreated, and (A) ASM
activity and (B) ceramide surface display were determined 2 hrs after infection. Non-infected cells served as control. Results represent mean 6 S.D. of
three independent experiments done in triplicates. (C and D) HBMEC were treated with indicated concentrations of the PLA2 inhibitor AACOCF3
30 min prior to infection with N. meningitidis MC58 or with indicated concentrations of the PLD inhibitor FIPI 1 h prior to infection and ASM activity
(C) and ceramide (D) surface display were determined 2 hrs after infection. Results represent mean 6 S.D. of three independent experiments done in
duplicates and are shown in relation to ASM activity and ceramide expression in MC58-infected HBMEC. ns = not significant. (E) Cells were treated
with 75 mU heparinase (striped bar) or heparin (black bars) prior to infection with N. meningitidis strain MC58, and ASM activity was assessed on these
and unmodified infected cells (w/o, white bar) after 2 hrs. Results represent mean 6 S.D. of three independent experiments done in triplicate. * P,
0.05, relative to untreated cells. (F and G) Cells were pretreated with 75 mU and 150 mU heparinase or indicated concentration of heparin or left
untreated (w/o) and infected with N. meningitidis strain MC58. Number of adherent (open bars) and invasive (filled bars) bacteria was determined by
gentamicin protection assays 4 hrs after infection. The data show mean values6 S.D. of three independent experiments done in duplicate. * P,0.05,
relative to cells infected without inhibitor.
doi:10.1371/journal.ppat.1004160.g003
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Figure 4. Inhibition of acid sphingomyelinase prevents N. meningitidis uptake by host cells. (A) ASM activity was determined in whole cell
lysates of HBMEC infected with N. meningitidis wildtype strain MC58 or unencapsulated strain MC58 siaD for 2 h. Data are compiled from three
independent experiments performed in triplicate. (B) Wildtype strain MC58 adherence on (left panel) and invasion into (right panel) HBMEC which
Differential Activation of ASM by Meningococci
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from MC58 (Fig. 6A and B). However, these 4 ST-11 cc isolates
proved to be significantly less effective at inducing ceramides in
HBMEC than the invasive MC58 strain as determined by flow
cytometry (Fig. 6C). Indicating that invasiveness of Neisseria
strains links to their ability to cause ASM activation, the activity of
the ASM in HBMEC extracts prepared 2 h p.i. with four the
MenC strains (WUE2121, DE7017, FAM18, DE6904) was
significantly lower than that induced by MC58 (Fig. 6E). These
strains, unlike MC58 (Fig. 1), also failed to induce ceramide-
enriched membrane platforms (data shown for WUE2121)
(Fig. 6D). We extended our study and included two further
isolates that belong to serogroup B (strains DE7901 and the carrier
isolate a4) (Table 1). Carrier isolate a4 was found to be less
adherent to HBMEC than the other strains tested, however, in line
with the findings observed for the serogroup C strains, both
isolates were found to be significantly less invasive and effective at
inducing ceramides on HBMEC (Fig. 6B and C).
To determine whether ASM activation and ceramide release is
specific to brain endothelial cells, we extended our study to
epithelial cells and included the human epithelial cell line FaDu.
As shown in figure S6, neither adherence nor invasion significantly
varied among strains tested at 4 h p.i. Cermide surface levels on
FaDu cells generally exceeded those detected on HBMEC,
however, did not detectably increase after infection with strain
MC58 or four MenC strains as determined by flow cytometry at
various time points (Fig. S6C, D).
Opc is sufficient to induce activation of ASM and
ceramide release
In order to define the meningococcal factor(s) involved in
differential ASM activation, we focussed on genes absent from the
ST-11 cc strains as compared to N. meningitidis MC58. Based on
data generated by a previous microarray comparative genome
hybridization (mCGH) study [45], 8 genes encoding for surface
and virulence-associated proteins were identified as potentially
involved in ASM activation also including the Opc outer
membrane protein (Fig. 7). This study revealed that the opc gene
is lacking in the three ST-11 cc strains (WUE2121, DE7017,
FAM18), while a hybridization signal was observed for ST-8 cc
strain DE6904 in the previous mCGH study, indicating the
presence of opc in strain DE6904. A detailed PCR amplification of
the opc gene, however, revealed a deletion of the opc gene also in
this strain resulting in lack of Opc expression (Fig. S7).
To define the role of Opc for ASM activation in detail, we made
use of two isogenic Opc-deficient knock out mutants MC58 opc
and MC58 siaD, opc [1]. HBMEC were infected with MC58 and
isogenic mutants and surface display of ceramide and ASM and
total ASM activity were determined. Isogenic Opc-deficient
mutants were less efficient at inducing ASM activation (Fig. 8A)
and surface display of ASM and ceramide (Fig. 8B and C)
compared to wildtype MC58 or isogenic unencapsulated strain
MC58 siaD. These data indicate that the absence of Opc accounts
for differential ASM activation.
To investigate whether the bacterial factor Opc is sufficient in
this process, the opc gene was cloned under the control of an IPTG
inducible prokaryotic expression vector and overexpressed in E.
coli BL21. Recombinant protein was expressed at high levels in E.
coli BL21 as demonstrated by immunoblot and flow cytometry
analysis (Fig. 8D). We next assessed the properties of the
recombinant Opc expressing E. coli to adhere to and enter into
HBMEC. Therefore, HBMEC were infected for 2 h with E. coli
BL21 expressing Opc or the parental E. coli strain at an MOI of
30. As expected, infection of HBMEC with Opc-expressing
bacteria significantly increased internalization (10-fold increase
of uptake), but not adherence (Fig. 8D). HBMEC infection with
Opc-expressing E. coli resulted in a 1.3 fold increase of ceramide
release compared to the parental E. coli strain (Fig. 8E). Moreover,
ASM activity in response to Opc-expressing E. coli increased
significantly measured at 2 h p.i (Fig. 8F). Together, these data
attribute an important role for the Opc protein in enhancement of
bacterial uptake driven by ASM activation.
N. meningitidis promotes ErbB2 recruitment in ceramide-
enriched platforms
There are numerous examples of cellular surface receptors
including CD95 [27], CD40 [31] or CD150 [41], which cluster
within ceramide-enriched platforms generated in response to ASM
activation. We therefore hypothezised that enhancement of N.
meningitidis uptake into HBMEC by Opc and HSPG driven ASM
activation might relate to concentration of receptors involved in
meningococcal invasion within these platforms. N. meningitidis
recruit the tyrosine kinase receptor ErbB2 (Her2/neu) to the sites
of bacterial adherence on endothelial cells [46]. Tyrosine
phosphorylation of ErbB2 has been shown to be required for
efficient uptake by promoting the phosphorylation of the actin-
binding protein cortactin [47]. To examine whether this receptor
is recruited and trapped into ceramide-enriched membrane
platforms, we compared the subcellular distribution of ErbB2 in
HBMEC before and after infection with N. meningitidis. In
uninfected cells, ErbB2 detected in fixed, unpermeablized cells
revealed an overall punctuate expression pattern (Fig. 9, second
row). Infection with N. meningitidis strain MC58 for 2 h, however,
caused enhanced re-distribution of ErbB2 to the site where
bacteria had attached and formed microcolonies (Fig. 9, first row),
where we also detected ceramide-enriched platforms. Formation
of ceramide-enriched platforms upon meningococcal exposure was
sensitive to ASM knockdown and remarkably, ErbB2 failed to
redistribute and cluster under these conditions as well (Fig. 9, third
row). To confirm involvement of HSPGs, HBMEC were
pretreated with either heparinase (150 mU) or heparin (100 mg/
ml) and infected with strain MC58 for 2 h. As shown in figure 9
(rows 5 and 6) formation of ceramide-enriched platforms upon
were preincubated with 10 mM amitriptyline (+ Ami, filled bars) or solvent (DMSO) only (control, open bars) within the time interval indicated were
determined by gentamicin protection assays. The data show mean values 6 S.D. of three independent experiments done in duplicate. * P,0.05,
relative to cells infected without inhibitor. (C) Adherence (white bars) and invasion (black bars) of the unencapsulated strain MC58 siaD were
determined on HBMEC pre-incubated with solvent only (w/o) or amitriptyline 4 h (left panel) or 8 h (right panel) following infection. Data are relative
values with solvent only set to 100 percent and show mean values6 S.D. of three independent experiments done in duplicate. (D and E) Intracellular
bacteria were determined in untransfected cells (w/o) or in HBMEC transfected with ASM-specific or control siRNA (con siRNA) 72 hrs prior to
infection with strain MC58 (D) and mutant strain MC58 siaD (E) for 4 h. The graph represents mean values 6 S.D. of three independent experiments
done in duplicate. * P,0.05, relative to cells transfected with the control siRNA. Genetic knockdown of ASM was determined in total RNA by RT-PCR
analysis. Amplification of b-actin served as control. (F and G) Mouse embryonic fibroblasts (MEFs) of wildtype (wildype fibroblasts) or ASM-deficient
(ASM2/2 MEFs) mice were infected with MC58 and MC58 siaD for 2 h. Intracellular bacteria were estimated at 2 h p.i. by gentamicin protection
assays. The graph represents mean value 6 S.D. of three different independent experiments done in duplicate. * P,0.05.
doi:10.1371/journal.ppat.1004160.g004
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meningococcal exposure was also sensitive to interference with
HSPGs and ErbB2 failed to redistribute under these conditions as
well. Altogether, these data show that the reorganization of
ceramide into large membrane platforms promotes lateral
redistribution and clustering of ErbB2, an important receptor
involved in N. meningitidis uptake.
Discussion
In this study we provide evidence for an important function of
the acid sphingomyelinase (ASM) in Opc-mediated internalization
of N. meningitidis into brain endothelial cells. Furthermore, we show
that activation of ASM occurs downstream of heparan sulfate
proteoglycans (HSPGs) and involves phosphatidylcholin phospho-
lipase C (PC-PLC) activity. The importance of ASM activation in
N. meningitidis uptake was strongly supported by its significant
reduction upon experimental (pharmacological and siRNA
mediated interference) or natural (NPDA fibroblasts) ablation of
the enzyme activity. ASM activation by Opc-expressing N.
meningitidis caused ceramide release resulting in formation of
extended ceramide-enriched membrane platforms, where ASM
and, most importantly, the tyrosine kinase receptor ErbB2,
involved in the cellular uptake of N. meningitidis, are co-displayed.
It is in response to a variety of stimuli also including ligation of
certain receptors that lysosomal ASM translocates to the outer
leaflet of the cell membrane to catalyze breakdown of sphingo-
myelin into ceramide. As relevant to our studies, the presence of
fatty acids, mono-, di-, and triacylglycerols as well as phosphati-
dylinositol has been implicated in ASM activation [48], and this
especially applies to diacylglycerol (DAG) released in response to
by PC-PLC, activated by the related species N. gonorrhoeae
[37,43,44]. Here, we show that interaction of N. meningitidis with
HSPGs stimulates ASM translocation and activation, and this
process also involves PC-PLC activity (Fig. 3). HSPGs function
primarily as initial, low affinity co-receptors that act to concentrate
pathogens on host cell surfaces, thereby increasing binding to
specific secondary receptors. For N. gonorrhoeae, ASM activation has
been found to be triggered upon Opa-mediated binding to HSPGs
[37], whereas ASM activation by N. gonorrhoeae in neutrophils
involves Opa52-mediated binding to CEACAM receptors [38].
CEACAM-mediated activation of ASM by N. meningitidis could be
excluded in our cell culture model system because this receptor is
not expressed on HBMEC (unpublished data). For N. meningitidis
uptake, it has been established that Opc links the bacterium to
vitronectin and/or fibronectin followed by binding to avb3 or
a5b1-integrins [1,2]. It is quite possible that the interaction of N.
meningitidis with integrins stimulates per se or contributes to ASM
translocation followed by ceramide release. This can, however,
only be addressed by a separate, thorough study which would
exceed the scope of the present manuscript.
During the interaction with endothelial cells, pilus mediated
adhesion of N. meningitidis has been shown to induce the clustering
and tyrosine phosphorylation of the host tyrosine kinase receptor
ErbB2 [46]. Activation of ErbB2 is required to support N.
meningitidis internalization [46], by promoting the phosphorylation
of the actin-binding protein cortactin and thus it is remarkable that
it co-segregates with ASM within ceramide-enriched platforms
generated downstream of meningococcal interaction with HSPGs
(Figs. 3, 9). This suggests that ASM and ceramide-induced
clustering and lateral segregation of ErbB2 in membrane platforms
function as an upstream prerequisite for ErbB2-supported
meningococcal internalization. For N. gonorrhoeae, ASM activation
is required for both the entry into professional and non-
professional phagocytes [37,38], however, the formation of large
ceramide-enriched membrane platforms and clustering of recep-
tors involved in N. gonorrhoeae uptake has not been demonstrated so
far.
Our findings are paralleled by the observation that measles virus
(MV) interaction with a pattern recognition receptor (DC-SIGN) is
followed by SMase catalyzed ceramide release and membrane
display of its entry receptor CD150 within ceramide-enriched
Figure 5. Niemann-Pick disease fibroblasts are significantly
less invaded by N. meningitidis. (A and B) ASM-deficient fibroblasts
of two Niemann-Pick disease type A (NPDA) patients (Pat.#1 and #2)
and two healthy control patients were infected with strain MC58 (A)
and MC58 siaD (B) and number of invasive bacteria were estimated by
gentamicin protection assays. The graphs represent mean value 6 S.D.
of three different independent experiments done in duplicate. * P,
0.05. (C) Intracellular and extracellular bacteria were detected in
infected NPDA (Pat. #1) and healthy controls fibroblasts by microscopy
4 hrs following infection with carboxyfluorescein succinimidyl ester
(CFSE)-labeled N. meningitidis strain MC58 siaD. Extracellular bacteria
stain positive with both Streptavidin-Alexa647 (red fluorescence) and
CFSE (green fluorescence), whereas intracellular bacteria (arrows) are
labeled with CSFE only. Size bars represent 5 mm.
doi:10.1371/journal.ppat.1004160.g005
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platforms on dendritic cells [41]. Thus, the generation of
ceramide-enriched membrane platforms might be a general motif
to mediate uptake of pathogens that applies to a very diverse range
of pathogens.
Whereas for MV one receptor is sufficient to promote viral
uptake, it is likely that further receptors might be recruited into
ceramide-enriched membrane platforms induced upon N. meningi-
tidis infection of endothelial cells, since adhesion of N. meningitidis to
Figure 6. MenC isolates are less efficient at activating ASM and membrane ceramide release on HBMEC. (A) Adherent and (B)
intracellular bacteria were evaluated in HBMEC infected with N. meningitidis wildtype strain MC58, four MenC strains (WUE2121, DE7017, FAM18,
DE6904) and two further MenB strains (DE7901 and a4) for 4 hrs by gentamicin protection assays. The graphs represent mean value 6 S.D. of four
independent experiments done in duplicate and show the percentage of recovered bacteria compared to MC58. * P,0.05. (C) Surface ceramide
levels on infected HBMEC were determined by flow cytometry. Representative histograms demonstrating surface expressions of ceramide on HBMEC
infected with DE7901, a4, WUE2121, DE7017, FAM18, DE6904 (green lines) compared to N. meningitidis strain MC58 (orange lines), uninfected cells
served as control (filled grey). (D) Ceramides were detected on HBMEC left uninfected (control) or infected with GFP-expressing strain WUE2121 for
2 hrs by immunofluorescence analysis. (E) Whole cell lysates of cells infected with the four MenC strains and strain MC58 were analyzed for ASM
activity. Data (mean 6 S.D.) are compiled from three independent experiments performed in triplicate. * P,0.05. SgC= serogroup C meningococci.
doi:10.1371/journal.ppat.1004160.g006
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epithelial cells has been shown to induce the formation of a specific
molecular complex, referred to as ‘cortical plaque’. ‘Cortical
plaques’ are enriched in ezrin, moesin, tyrosine-phosphorylated
proteins, ICAM-1, CD44 and EGFR [49,50]. In addition,
meningococcal adhesion on human endothelial cells leads to the
redistribution of the Par3/Par6 polarity complex, which is
recruited underneath meningococcal microcolonies, weakening
the barrier properties of the blood-cerebrospinal fluid barrier
[46,51]. It is tempting to speculate that molecules of the ‘cortical
plaque’ or even polarity complex components cluster in ceramide-
enriched membrane platforms underneath meningococcal micro-
colonies.
It is important to note that ASM-inhibition prevented
meningococcal uptake, but did not alter adherence regardless of
whether the enzyme was inhibited by pharmacological (amitrip-
tyline) or genetic approaches (siRNA ablation, ASM2/2 MEFs
and NPDA fibroblasts) (Fig. 5). Moreover, there is apparently a
peak of ASM translocation at 2 hrs as measured by flow
cytometry, which does, however, not resolute subcellular localiza-
tion of ceramide release. This is much better reflected by detection
of ceramide-enriched platforms by immunofluorescence, which,
by nature, is not quantitative. Neither ASM alone nor ceramides
per se are operative in supporting N. meningitidis invasion, but
rather act to sort surface and membrane proximal complexes
required which may not be completed, but ongoing over the time
interval monitored. It is also possible that ceramide release assists
in alterations of membrane curvature as required for invasion
which may also be time consuming. It has, for instance been
shown in an ASM dependent bead uptake assay that increase in
membrane order (reflecting ASM activity) peaked already after
5 mins, while bead uptake in macrophages was completed only
after 1 hr [52].
Previous studies have shown that P. aeruginosa and Staphylococcus
aureus activate ASM and trigger the formation of ceramide-enriched
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Figure 7. Distribution of surface and virulence-associated
proteins. Only surface and virulence-associated proteins are shown
that are variably present among the 5 meningococcal strains compared.
Sg = serogroup, CC= clonal complex. Figure adapted from [45].
doi:10.1371/journal.ppat.1004160.g007
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membrane platforms [39]. However, the bacterial factors responsi-
ble for ASM activation have not been identified for these
microorganisms so far. In our system, ASM activation and ceramide
release were assigned to Opc, and the differential ability of
meningococcal clonal complexes to promote ASM activation could
be assigned to expression of Opc (Fig. 6 and 8).
Studying the interaction of N. meningitidis with host cells is
complicated by the high variability of meningococcal isolates
which can be classified by multi locus sequence typing (MLST)
based on the polymorphisms in seven housekeeping genes [53].
Moreover, meningococcal isolates can be clustered to clonal
complexes comprising isolates that share identical nucleotide
sequences for at least four MLST loci. Isolates from asymptomatic
carriers are more diverse that those recovered from patients with
invasive disease [54,55]. A few so called ‘hyper-invasive’ isolates
are responsible for most reported diseases and may spread rapidly
through human populations, resulting in countrywide epidemics of
meningococcal meningitis [54–57]. Two epidemiological studies
reported outbreaks of meningococcal strains of the ST-11 cc that
tended to cause severe sepsis with fatal outcome but rarely caused
meningitis [19,20]. Employing four MenC isolates belonging to
ST-11/ST-8 cc that lack the opc gene, we demonstrated that all
four MenC strains induced significant less activation and
translocation of ASM in endothelial cells, followed by significant
less accumulation of ceramide on the cell surface and, therefore,
failed to trigger the formation of ceramide-enriched platforms
(Fig. 6). In line with a proposed critical role for ASM for
meningococcal uptake, all ST-11 cc strains tested in this study
proved to be significantly less invasive into HBMEC compared to
strain N. meningitidis MC58. This indicated a specific stimulation of
ASM by the Opc-mediated interaction of N. meningitidis with
endothelial cells. The contribution of Opc was underlined by using
recombinant E. coli expressing a functional form of this protein,
demonstrating that Opc is sufficient to trigger ASM activation
followed by accumulation of ceramide within the outer leaflet of
the plasma membrane (Fig. 8). However, since the differences
between Opc expressing and non-expressing strains are about
30%, further candidates might also contribute to ASM activation
Figure 8. Opc protein contributes to ASM activation and ceramide cell surface release. HBMEC were infected with N. meningitidis wildtype
strain MC58, isogenic unencapsulated strain MC58 siaD and two isogenic strains lacking Opc expression (MC58 opc and MC58 siaD, opc) for 2 h. (A)
ASM activity was measured in whole cell lysates of HBMEC infected with N. meningitidis wildtype strain MC58 or isogenic mutants. (B) ASM
translocation to the outer leaflet was determined by flow cytometry. (C) In parallel, surface ceramide levels on HBMEC were determined in infected
cells. All data are mean 6 S.D. from three independent experiments performed in triplicate. Values are expressed as the percentage of ceramide
expression, ASM translocation and activity in cells infected with Opc-deficient strains compared to parental strains. * P,0.05. (D) Expression of
recombinant Opc in E. coli BL21. Expression of Opc was analyzed either in bacterial lysates by Western Blotting or by flow cytometry analysis using a
monoclonal anti-Opc antibody. As a negative control E. coli not transformed with recombinant proteins were used. Representative histograms
demonstrating surface expressions of Opc on E. coli BL21 (filled line) compared to parental strains (open line). Adhesion and invasion to HBMEC of an
E. coli strain recombinantly expressing Opc (grey bars) or the parent strain (black bars) were determined by gentamicin protection assays. Results
represent mean 6 S.D. of three independent experiments done in triplicate and show the percentage of recovered bacteria compared to not
transformed E. coli. ** P,0.01. (E and F) Cells were infected with Opc-expressing E. coli and parental E. coli strain and ceramide accumulation and ASM
activity was determined as described above.
doi:10.1371/journal.ppat.1004160.g008
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Figure 9. N. meningitidis infection promotes ErbB2 recruitment in ceramide-enriched platforms. HBMEC were transfected with siRNAs
against ASM (+ ASM siRNA) or control siRNA (2 ASM siRNA) for 72 hrs and cells were left uninfected (control cells) (row 2 and 4) or were infected with
a GFP expressing isolate of strain MC58 (row 1 and 3). Cells were fixed and stained for ErbB2 with an IgG2a anti-ErbB2 antibody and secondary Cy3-
conjugated antibodies, followed by ceramide staining with an anti-ceramide antibody and secondary Alexa350-conjugated anti-mouse-IgM antibody.
Infection caused enhanced re-distribution of ErbB2 to the site of attached bacteria. Moreover, confocal microcopy revealed co-clustering of ErbB2 in
ceramide-enriched platforms upon infection (arrows). The studies are representative for 3 similar results. Size bars represent 10 mm. (Row 5 and 6)
HBMEC were pretreated with 150 mU heparinase or 100 mg/ml heparin and infected with a GFP expressing isolate of strain MC58. Cells were fixed
and stained for ErbB2 followed by ceramide staining. The studies are representative for 2 similar results. Size bars represent 10 mm.
doi:10.1371/journal.ppat.1004160.g009
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and thus ceramide generation, such as the PorB, NarE or the
VapD-like protein, that are also absent in all ST-11/ST-8 cc
strains (see Fig. 7).
The critical role of the ASM/ceramide system in uptake of
certain bacterial pathogens suggests this system as potential
therapeutical target. Amitriptyline used to inhibit ASM in this
and several other studies is in clincal use for treatment of
depression, and currently tested in a randomized, double-blind,
placebo-controlled phase IIb multicenter study for the therapy of
patients with cystic fibrosis (CF), where it was found to improve the
lung function and to reduce ceramide in the lung cells of CF
patients [58]. In contrast to CF, an inherited chronic disease that
affects the lungs and digestive system, meningococcal meningitis
develops quickly and outcome often depends on how soon
antibiotics are given after the illness starts. Approximately 50–
60% of patients with systemic meningococcal infection present
with clinical symptoms of distinct meningitis. A potentially neuro-
protective therapeutic agent blocking the ASM would be
administered for a short period, should be well tolerated and,
most important, must immediately inhibit the ASM in endothelial
cells. Amitriptyline and structurally similar molecules functionally
inhibit the ASM by inducing a degradation of the enzyme and,
therefore, their action might be too slow. Thus, a drug targeting
the ASM in N. meningitidis infection should inhibit directly and
immediately the ASM to provide a beneficial effect in patients
suffering from meningococcal meningitis.
Materials and Methods
Bacterial strains
Neisseria meningitidis strain MC58, a serogroup B isolate (United
Kingdom, 1983) of the ST-32 clonal complex (cc) was character-
ized as serotype B:15:P1.7,16 (kindly provided by E. R. Moxon).
Non-encapsulated mutant MC58 siaD, Opc-deficient mutant
strains MC58 opc and MC58 siaD, opc were previously described
[1] (Table 2). Meningococcal isolates of the ST-11/ST-8 cc of
serogroup C (N. meningitidis strains WUE2121, DE7017, FAM18,
DE6904) and isolates of serogroup B (a4 and DE7901) were taken
from a collection by Schoen and colleagues [45] and are
summarized in table 1. All strains were tested for Opc, NadA
and NarE expression (Fig. S7). Polyclonal antibody raised against
NarE was kindly provided by Dr. F. Gu¨nther (Medical Microbi-
ology and Hygiene, University of Heidelberg). Opc expression
was analyzed by PCR using primer pair RA3 59- CATCT-
CAAGTCTCGTCATTCC-39 and RA4: 59-AGCCTGTG-
TAAAGATCGATAC-39, kindly provided by Dr. H. Claus. Lack
of opc gene was verified by PCR using primer pair RA1 59-
CAAAGCGCACATCACCGTC-39 and RA2 59-CCATCAAAT-
GAATATCCATACC-39. Confocal microscopy was performed
with a derivative expressing a green fluorescent protein from the
plasmid pEG2-Ery [59], which also contains an erythromycin-
resistance gene.
Cell culture and infection assays
The simian virus 40 large T antigen-transformed human brain
microvascular endothelial cells (HBMEC) were kindly provided by
K. S. Kim [60] and were cultured as previously described [1].
Cells between the 10th and 25th passages were used for infection
assays at a density of 16105 per well with bacteria at a multiplicity
of infection (MOI) of 10–30 unless indicated otherwise as
described previously [1]. Infections were carried out in the
presence of 10% human serum (HS) supplemented RPMI
medium. HS were derived from a serum pool (voluntary staff)
and heat-inactivated for 30 min at 56uC [1]. Wildtype strain N.
meningitidis MC58 and the isogenic capsule deficient mutant were
tested repeatedly for pili, Opa and Opc expression before
application to infection assays and after reisolation from the cell
culture using Western blot analysis. HBMEC/cib was kindly
provided by Tomomi Furihata [61]. HBMEC/cib were generated
from a human primary BMEC-derived cell line immortalized with
both the temperature-sensitive mutant of the simian virus 40 large
tumor antigen (tsSV40T) and the human telomerase reverse
transcriptase subunit (hTERT) [61]. Human ASM-deficient
fibroblasts were obtained from patients with Niemann-Pick
Disease type A (NPDA) and maintained in RPMI medium 1640.
Mouse embryonic fibroblasts (MEFs) were derived from ASM
knockout mice or wildtype embryos and grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
calf serum (FCS). FaDu (ATCC HTB 43), an epithelial-like
human pharynx cell line from cell carcinoma, was maintained in
DMEM supplemented with 10% FCS.
Reagents and antibodies
When indicated, cells were exposed to amitriptyline (5 mM,
7.5 mM and 10 mM), Heparinase III (from Flavobacterium
heparinum [H8891]; 75 mU and 150 mU) and heparin (heparin
sodium salt; 10 mg/ml, 50 mg/ml and 100 mg/ml) (all: Sigma-
Aldrich (Sigma-Aldrich, Taufkirchen, Germany)), phosphatidyl
choline-specific phospholipase C (PC-PLC) inhibitor [D609]
(100 mM) or phospholipase A2 inhibitor AACOCF3 (0.1 mM,
5 mM and 10 mM) or phospholipase A2 inhibitor FIPI (20 nM,
100 nM and 750 nM) (all: Tocris Bioscience, Bristol, UK).
6-Hexadecanoylamino-4-methylumbelliferyl-phosphorylcholine
(HMU-PC) was purchased from Moscerdam Substrates (Am-
sterdam, The Netherlands). D609, AACOCF3, FIPI and
amitriptyline did not affect the viability of bacteria or HBMEC
judged by survival assays and microscopic or flow cytometry
examination. For flow cytometry, fluorescence microscopy and
Western blotting analyses the following primary antibodies were
used: mouse monoclonal antibody (mAb) anti-ASM IgG (clone
ab74281, Abcam, Cambridge, UK), mouse mAb anti-ceramide
IgM (clone MID 15B4, Alexis), polyclonal rabbit anti-ASM IgG
(H-181, Santa Cruz), mouse mAb anti-ErbB2/Her2/neu IgG2a
(clone Neu (C3), Santa Cruz). Secondary Cy3-conjugated goat
anti-mouse IgM, goat anti-rabbit IgG (H+L) Cy3 and Cy5
Table 2. List of N. meningitidis mutant strains used in this study.
Mutant strains Characteristics
MC58 siaD Isogenic mutant of the pathogenic isolate MC58, deficient in capsule expression, [1]
MC58 opc Isogenic mutant of the pathogenic isolate MC58, deficient in Opc expression, [1]
MC58 siaD, opc Isogenic mutant of MC58 siaD, deficient in capsule and Opc expression, [1]
doi:10.1371/journal.ppat.1004160.t002
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conjugates, Cy5-conjugated goat anti-mouse IgM, Fluorescein
isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (H+L)
and Tetramethylrhodamine isothiocyanate (TRITC)-conjugated
goat anti-rabbit IgG (H+L) (all: Dianova (Dianova, Hamburg,
Germany)). Alexa350-conjugated goat anti-mouse IgM (m-chain
specific) was from Invitrogen. Nitrocellulose membranes were
incubated with horseradish peroxidase (HRP)-conjugated sec-
ondary goat anti-mouse IgG (bacteria) (Sigma-Aldrich, St.Louis,
MO) or HRP-conjugated secondary goat-anti-mouse IgM (spot
assay) (Dianova).
Expression of meningococcal proteins in E. coli
In order to generate a Opc-expressing Escherichia coli strain, the
opc gene was amplified by PCR from chromosomal DNA of N.
meningitidis strain MC58 using the primer pair OpcA-MC58-sense
(59-CGGATCCATGGGCAAAAAAACAGTTTTT -39, NcoI site)
and OpcA-MC58-antisense (59- CCCGCTCGAGTCAGAA-
TTTTATGCCGACGCG -39, XhoI site). The PCR product was
digested with NcoI/XhoI and cloned in pET28a(+) (Novagen). The
pET28a(+) vector encoding Opc protein were transformed in E.
coli BL21 (DE3; from Novagen). Cloned opc gene was verified by
sequence analysis. Opc expression was controlled by immunoblot
analysis using monoclonal anti-Opc antibodies (clone B306, kindly
provided by M. Achtman).
Western blot
For Western blot experiments, overnight cultures of meningo-
cocci were inoculated into Polyvitex (1% (v/v)) supplemented
Proteose Peptone medium (PPM+) and grown to mid-log phase
(OD600 = 0.5–0.6) at 200 r.p.m and 37uC. 4610
8 bacteria were
harvested by centrifugation, resuspended in 50 ml of sample
solution (25% Tris 250 mM pH 6.8, 50% Glycerin, 10% SDS (w/
v) and 25% b-Mercaptoethanol) and heated to 100uC for 10 min.
Protein concentration of each sample was measured using the
BCA assay (Thermo Scientific, USA) and 10 ml of a 300 mg/ml
final concentration of denatured protein per sample was used for
electrophoresis, blotting and incubation with anti-Opc, anti-NadA
or anti-NarE. Detection was performed with the Pierce chemilu-
minescence Western blotting kit (Thermo Scientific, USA).
Ceramide detection
Cell surface ceramide was detected using a spot assay previously
described [41]. In brief, 56105 cells were fixed in 3.7%
formaldehyde for 15 min at 37uC, scraped from the culture flask,
pelleted, washed twice with 16 PBS and incubated with anti-
ceramide IgM (clone MID 15B4) for 45 min at RT. Cell bound
antibody was desorbed for 30 sec in 20 ml 100 mM glycine-HCl,
pH 3.0, and spotted on nitrocellulose following neutralization in
20 ml Tri-HCl, pH 8.0. Antibody was detected with secondary
peroxidase -conjugated goat-anti-mouse IgM (1:2500) and after
washing (3 times for 10 min in PBS-Tween (PBS-T)), enhanced
chemiluminescence was used to visualize spots.
ASM activity assay
ASM activity assays were performed using a commercial assay
kit according to the manufacturer’s instructions (Sphingomyelinase
fluorometric assay Kit, Cayman Chemical, Ann Arbor, MI). In
brief, 56105 cells/well were seeded on gelatin-coated 6-well tissue
culture plates (Sarstedt Inc., Newton, NC) and infected 72 hrs
later at an MOI of 10. Cells were harvested after removal of the
medium and a washing step in PBS by scraping from the culture
flask in 500 ml ice cold PBS and pelleted by centrifugation at 800 g
for 10 min at 4uC. Pellets were resuspended in 300 ml ice cold
SMase acid solution, briefly sonicated (20 pulses, 1 s), and lysates
were separated from cellular debris by centrifugation at 20,0006g
for 10 min at 4uC. Pellets were resolved in 100 ml SMase acid
dilution buffer. For the reaction 10 ml sample per well was applied
and incubated for 30 min with Sphingomyelin substrate at 37uC
following 100 ml enzyme mixture (as provided by the manufac-
turer) for 30 min at 37uC. The subsequent analysis was performed
by using an Infinite F200 Pro Reader (Tecan Group, Maennedorf,
Switzerland) with an excitation wavelength of 540 nm and an
emission wavelength of 590 nm.
NSM activity assay
NSM activity assays were performed using the fluorescent
substrate 6-Hexadecanoylamino-4-methylumbelliferyl-phospho-
rylcholine (HMU-PC) (Moscerdam). In brief, 56104 cells/well
were seeded 72 h prior to infection on gelatin-coated 24-well tissue
culture plates (Sarstedt Inc., Newton, NC), grown to a density of
approximately 26105 cells per well and infected at an MOI of 10.
Cells were trypsinised in 200 ml trypsin following addition of
800 ml RPMI medium transferred to a new 1.5 ml tube. The
suspensions were centrifuged at 800 g for 5 min and pellets were
resuspended in 100 ml lysis buffer (20 mM Hepes pH 7.4, 2 mM
EDTA pH 8.0, 5 mM EGTA pH 8.0, 1 mM sodium vanadate,
10 mM beta-glycerolphosphate, 5 mM DTT, protease inhibitor
cocktail). After 5 cycles of freezing-thawing in methanol/dry ice,
cell suspensions were centrifuged for 5 min at 1,600 rpm at 4uC.
Supernatants were transferred to a 1.5 ml glass tube, overfilled
with 500 ml PBS and pelleted for 1.5 h at 26,000 rpm at 4uC in an
SW28 rotor (Beckman). The pellets containing the membrane
fractions were resuspended in 40 ml lysis buffer and vortexed
gently. Finally, 10 ml resuspension buffer (20 mM Hepes pH 7.4,
2 mM EDTA pH 8.0, 10 mM MgCl2, 0.1 mM sodium vanadate,
10 mM beta-glycerolphosphate, 5 mM DTT, 7,5 mM ATP and
0.2% Triton-X-100), 10 ml HMU-PC substrate, 10 ml membrane
fraction and 1.8 ml Tric HCl (pH 8.0) were mixed and incubated
at 37uC overnight. Reaction was stopped by addition of 200 ml
stop buffer and enzyme reaction was measured on an Infinite F200
Pro Reader with an excitation wavelength of 404 nm and an
emission wavelength of 460 nm.
Assay of PC-PLC activity
PC-PLC activity assays were performed using a commercial
assay kit according to the manufacturer’s instructions (EnzChek,
Invitrogen). Cell sonicates were prepared according to the
methods described by Gomez-Cambronero et al. [62]. For the
reaction 100 ml sample (in 1X PC-PLC buffer) per well was
applied and incubated with 100 ml of 1X PC-PLC substrate (dye-
labelled glycerol-phosphoethanolamine) (as provided by the
manufacturer) for 30 min at RT. The cleavage releases the dye-
labeled diacylglycerol, which produces a positive fluorescence
signal that can be measured. The subsequent analysis was
performed by using an Infinite F200 Pro Reader with an
excitation wavelength of 490 nm and an emission wavelength of
520 nm.
siRNA transfection
An ASM targeting siRNA were designed to generate dsRNA for
post- transcriptional gene silencing of the ASM gene. The
following sequences were used for siRNA knockdown experiments:
ASM sense 59-GGUUACAUCGCAUAGUGCCTT-39 and ASM
antisense 59-GGCACUAUGCGAUGUAACCTT-39. SiRNA ol-
igonucleotides were obtained from Sigma-Aldrich (Sigma-Aldrich,
St.Louis, MO). As negative control scrambled non-targeted
control siRNA [sc-37007] (Santa Cruz Biotechnology, Santa
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Cruz, CA) were used. Control nonsilencing siRNA and ASM
siRNA were transiently transfected into HBMEC growing in
HBMEC medium using 3 ml of HiPerfect Transfection Reagent
(Qiagen) according to the manufacturer’s instructions. Protein
knockdown efficiencies by siRNA transfection were verified by
reverse transcription PCR after 72 h of transfection.
Reverse transcription PCR
RNA was extracted from HBMEC tissue using RNeasy Mini
kits (Qiagen). cDNA was synthesized from 1.0 mg of RNA using
Oligo-dT primers (Invitrogen) using Superscript II Reverse
Transcriptase (Invitrogen) according to the manufacturer’s
instructions. For PCR, the mixture was denaturated at 95uC for
3 min and the target genes were amplified by 35 cycles of reaction:
ASM (95uC 30 s, 61uC 30 s, 72uC 1 min) or b-actin (95uC 30 s,
61uC 30 s, 72uC 1 min). Primers used for real time PCR are as
follows: forward human ASM, 59-CCTTTTGATATGGTG-
TACTTGGAC-39, reverse human ASM, 59-GTAATAATTC-
CAGCTCCAGCTCT-39; forward human b-actin, 59-GGAC-
TTCGAGCAAGAGATGG-39, reverse human b-actin, 59-AG-
CACTGTGTTGGCGTACAG-39.
Flow cytometry
HBMEC were washed twice with PBS and resuspended in ice-
cold fluorescence-activated cell sorting (FACS) buffer (5% FCS
and 0.1% NaN3 in PBS). 46105 cells were incubated for 90 min
with either mouse mAb anti-ASM IgG antibody (1:250 in FACS
buffer) or mouse mAb anti-Ceramide IgM antibody (mAb 15B4)
(1:30 in FACS buffer), followed by washing and incubation with
Cy5-conjugated goat anti-mouse IgM (1:300 in FACS buffer) or
Cy5-conjugated goat anti-mouse IgG. After the incubation cells
were washed and resuspended in 500 ml FACS buffer for the
measurement. 10,000 cells were analyzed using a FACSCalibur
(BD Bioscience) and the CellQuest Pro software (version 5.2). For
determination of Opc expression on the surface of E. coli, E. coli
BL21(DE3) pET-opc cells were grown and expression of the Opc
protein was induced by adding IPTG to a final concentration of
1 mM and incubating the cells for another hour at 37uC under
shaking (200 rpm). Cells were harvested by centrifugation and
washed twice with PBS suspended to a final OD600 of 0.1/ml for
further experiments. Cells were again centrifuged and resuspended
in 1 ml FACS buffer. After centrifuging the cells for 10 min at
4,500 g (VWR International GmbH, Darmstadt, Germany), the
obtained cell pellet was suspended with 200 mL of mouse anti Opc
antibody (clone B306, diluted 1:100 in FACS buffer) and
incubated for 60 min on ice. Subsequently cells were washed
twice with FACS buffer and bacterial pellets were resuspended in
20 mL of secondary Cy5-conjugated anti-mouse IgG antibody
(1:300 in FACS buffer) and incubated for 30 min in the dark on
ice. After washing twice, the cell pellets were finally suspended in
1.5 mL of FACS buffer. The samples were analyzed using a flow
cytometer using a FACSCalibur and the CellQuest Pro software
(version 5.2).
Fluorescence microscopy
Ceramide staining. Cells grown on glass coverslips to
confluence were infected with GFP-expressing N. meningitidis strain
MC58 (MOI of 30) for indicated time points, washed, fixed for
15 min in 3.7% paraformaldehyde in PBS, incubated for 45 min
in blocking buffer (PBS/1% FCS/2% BSA) and stained with
primary anti-ceramide IgM antibody mAb 15B4 (1:50 in blocking
buffer) for 45 min, followed by three PBS washing steps and
incubation with Cy3-labeled anti-mouse IgM antibodies (1:200 in
blocking buffer) for further 45 min. Stained cells were viewed and
photographed by using a Leica SP5 (Leica Microsystems, Wetzlar,
Germany). Images were processed with LAS AF (Leica) and
ImageJ software and documented using Adobe Photoshop CS.
MenC strain and ceramide: Cells were infected with GFP expressing N.
meningitidis strain WUE2121 (MOI of 30), a derivate of WUE2121
expressing GFP from the plasmid pEG2-Ery [59] as described for
strain MC58.
Niemann-Pick disease type A cell staining. For determi-
nation of extra- and intracellular bacteria a double cycle antibody
staining protocol was used, as recently described [1]. Samples were
viewed and photographed by using a Zeiss Axio Imager.Z1
fluorescence microscope.
Co-localisation of ASM and ceramide. For co-localisation
of ASM and ceramide, cells were infected with bacteria for
indicated time points. After the indicated time of stimulation, the
cells were washed and fixed for 15 min in 3.7% paraformaldehyde
in PBS. Cells were washed, blocked for 45 min and incubated for
45 min each with a rabbit anti-ASM antiserum (1:100 dilution,
clone H-181, Santa Cruz) and anti-ceramide mAb 15B4 (1:100
dilution), respectively. The anti-ASM antibody was visualized with
a Cy5-conjugated anti-rabbit Ig antibody and the anti-ceramide
antibody was visualized with a Cy3-conjugated anti-mouse IgM
antibody. Co-localization was monitored with a Leica SP5
confocal laser scanning microscope using a Plan Apo 636/1.4
NA oil immersion objective. Fluorescence signals of labeled
specimens were serially recorded with appropriate excitation
wavelengths and emission bands for Cy3 or Cy5, respectively, to
avoid bleedthrough. Images were processed as described above.
Co-localisation of ErbB2 and ceramide. For co-localisa-
tion of ErbB2 and ceramide, cells were stained with primary anti-
ErbB2 IgG2a (1: 150 in blocking buffer) and anti-ceramide
antibody as described above. The anti-ErbB2 antibody was
visualized with a Cy3-conjugated anti-rabbit Ig antibody, whereas
the anti-ceramide antibody was visualized with an anti-mouse (m-
chain specific) Alexa350-conjugated secondary antibody.
Statistical analysis
Statistical differences between groups were calculated using the
Student’s unpaired t-test (two-tailed) using Excel. P-values #0.05
were considered significant, P-values #0.01 were considered
highly significant.
Supporting Information
Figure S1 N. meningitidis induces a transient formation
of ceramide-enriched membrane platforms on brain
endothelial cells (HBMEC). (A) Lower magnification image of
HBMEC that were infected with a GFP-expressing wildtype strain
MC58 for 2 h (bottom panels) or left uninfected (control cells,
upper panels), fixed, left intact, stained with anti-ceramide
antibodies and secondary Cy3-conjugated anti-mouse-IgM anti-
bodies and analyzed by confocal microscopy. The data are
representative for 3 similar studies. Size bars represent 20 mm. (B)
HBMEC were infected with wildtype strain MC58 for a 4 hrs
period, fixed after 1 h, 2 h, 3 h and 4 h p.i., left intact, stained
with anti-ceramide antibodies and secondary Cy3-conjugated anti-
mouse-IgM antibodies The data are representative for 2 similar
studies. Size bars represent 20 mm.
(TIF)
Figure S2 N. meningitidis infection does not activate the
neutral sphingomyelinase (NSM) in HBMEC. HBMEC
were infected with N. meningitidis wildtype strain MC58 for the
indicated time points or left uninfected (control). Membrane
fractions of infected and uninfected control cells were prepared
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and analyzed for NSM activity as described under ‘‘Materials and
Methods’’. The data are the mean 6 S.D. from three independent
experiments performed in triplicate. ns = not significant.
(TIF)
Figure S3 N. meningitidis infection causes membrane
ceramide accumulation on HBMEC/cib. Surface ceramide
release on N. meningitidis MC58 infected HBMEC/cib (for control,
uninfected HBMEC/cib) was determined by flow cytometry. An
isotype antibody served as a negative control in staining
experiments. All data show mean values 6 S.D. of three
independent experiments done in duplicate. * P,0.05, ** P,
0.01, *** P,0.001, relative to uninfected control cells.
(TIF)
Figure S4 N. meningitidis infection activates phospha-
tidylcholine-specific phospholipase C (PC-PLC) in
HBMEC. HBMEC were treated with the PC-PLC inhibitor
D609 (100 mM) 30 min prior to infection with N. meningitidis
MC58 (open bars) or were left untreated (black bars), and PC-PLC
activity was determined at indicated time points using a
commercial assay kit. Non-infected cells served as control. Results
represent mean 6 S.D. of two independent experiments done in
triplicates. * P,0.05.
(TIF)
Figure S5 Immunofluorescence of Niemann-Pick dis-
ease (NPDA) fibroblasts infected with N. meningitidis.
Lower magnification image of NPDA (Pat. #1) and healthy
controls fibroblasts infected with CFSE-labeled N. meningitidis strain
MC58 siaD at 4 hrs p.i. Extracellular bacteria stain positive with
both Streptavidin-Alexa647 (red fluorescence) and CFSE (green
fluorescence), whereas intracellular bacteria (arrows) are labeled
with CSFE only.
(TIF)
Figure S6 Estimation of adherence and invasion of N.
meningitidis strains to FaDu cells and release of
ceramide. (A) FaDu cells were infected with strain MC58 and
four MenC strains (WUE2121, DE7017, FAM18, DE6904) for
4 hrs p. i. and the number of adherent and invasive bacteria was
estimated. The graphs represent mean value 6 S.D. of three
different independent experiments done in duplicate. * P,0.05.
(B) Relative amount of intracellular bacteria compared to strain
MC58. (C) FaDu cells were infected with strain MC58 for a 4 hrs
time period and surface ceramide release was determined at
indicated time points by flow cytometry. Representative FACS
analyses on FaDu cells infected with strain MC58, control,
uninfected FaDu. Open histograms indicate isotype control, filled
histograms show ceramide staining. (D) Surface ceramide release
on FaDu cells that were either left uninfected (control) or were
infected with MC58 and four MenC strains (WUE2121, DE7017,
FAM18, DE6904) was determined by flow cytometry. Open
histograms indicate isotype control, filled histograms show
ceramide staining. All data show mean values 6 S.D. of three
independent experiments done in duplicate. ns = not significant.
(TIF)
Figure S7 Characterization of expression of adhesins of
MenC strains used in this study. Western blot analysis of
Opc, Opa, NadA and NarE expression of whole bacterial lysates:
MC58, DE6894, WUE2121, DE7017, FAM18, DE6904. As a
negative control appropriate isogenic knock out mutants were
included: MC58 opc, MC58 Opa-, MC58 nadA and MC58 narE.
(TIF)
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